Loss of heterozygosity is a significant oncogenetic mechanism and can involve a variety of mechanisms including chromosome loss, deletion, and homologous interchromosomal mitotic recombination. Analysis of H-2 antigenloss variants from heterozygous murine cell lines provides an experimental system to estimate the relative contributions of different mechanisms for allele loss and to compare the chromosomal patterns of mitotic and meiotic recombination. Cytotoxic anti-H-2D antibodies and complement were used to isolate 161 independent target antigen-negative clones from H-2d/H-2b heterozygous cell lines; of these, 131 (84.5%) lost the allele encoding the target antigen. Allele-loss variants were typed and scored as either heterozygous or homozygous for six H-2D-proximal chromosome 17 markers and for one distal marker by restriction enzyme-site variations and Southern analysis. A single mitotic crossover could account for 50 clones (37%), with heterozygosity for at least one proximal marker and loss of heterozygosity for all markers distal to the putative recombination site. Eighty-two allele-loss variants (60%) were homozygous for all markers; the origin of these clones could be either chromosome loss or mitotic recombination between the centromere and the most proximal marker. Only 4 clones (3%) arose through more complex events such as multiple crossovers or deletion. A mitotic linkage map for mouse chromosome 17 was constructed, and the gene order deduced from somatic recombination was identical to that obtained by conventional transmission genetics. These results demonstrate that mitotic recombination is a common event leading to allele loss, in spite of the lack of evidence for frequent somatic palring of homologous chromosomes. Mitotic mapping provides a defined system for comparison of mitotic and meiotic recombination and may lead to practical advances for elucidating somatic mechanisms of oncogenesis and for gene therapy in targeting mutations to specific sites through homologous recombination.
H-2d/H-2b heterozygous cell lines; of these, 131 (84.5%) lost the allele encoding the target antigen. Allele-loss variants were typed and scored as either heterozygous or homozygous for six H-2D-proximal chromosome 17 markers and for one distal marker by restriction enzyme-site variations and Southern analysis. A single mitotic crossover could account for 50 clones (37%), with heterozygosity for at least one proximal marker and loss of heterozygosity for all markers distal to the putative recombination site. Eighty-two allele-loss variants (60%) were homozygous for all markers; the origin of these clones could be either chromosome loss or mitotic recombination between the centromere and the most proximal marker. Only 4 clones (3%) arose through more complex events such as multiple crossovers or deletion. A mitotic linkage map for mouse chromosome 17 was constructed, and the gene order deduced from somatic recombination was identical to that obtained by conventional transmission genetics. These results demonstrate that mitotic recombination is a common event leading to allele loss, in spite of the lack of evidence for frequent somatic palring of homologous chromosomes. Mitotic mapping provides a defined system for comparison of mitotic and meiotic recombination and may lead to practical advances for elucidating somatic mechanisms of oncogenesis and for gene therapy in targeting mutations to specific sites through homologous recombination.
In comparison to meiotic recombination, homologous interchromosomal recombination is a rare event in mammals. Chromosomes do not appear to pair regularly during mitotis and synaptonemal complexes in somatic cells are difficult to demonstrate; even in interphase cells in situ hybridization using chromosome-specific probes generally reveals two discrete regions of staining, implying a lack of pairing of homologous chromosomes (1) . Prior to the advent of DNA probes, Klein and her colleagues (2) (3) (4) conducted extensive sets of experiments in which H-2-heterozygous tumors were transplanted to hosts that shared one, but not the other, H-2 haplotype with the tumor. Serological analysis of tumor cells surviving the selective pressure of the host's immune response indicated that the tumor variants no longer expressed the incompatible H-2 antigens. Rajan and coworkers (5, 6) , using elegant antibody and complement selection protocols, demonstrated that selection did not induce H-2 antigen loss but rather allowed the outgrowth of preexisting mutant cells, and later provided the first solid evidence for mitotic recombination in mammalian cells (7) . Using DNA probes, they found that loss of H-2 antigen expression resulted from loss of the target haplotype in some variants; a few of these haplotype-loss variants remained heterozygous for the proximal isozyme marker, Glo-I (glyoxalase 1). The most parsimonious interpretation of this result was that homologous interchromosomal mitotic recombination had occurred in the Glo-l-H-2K interval proximal to the selected (targeted) locus. Mitotic recombination in mammals has been confirmed in several experimental systems (8) (9) (10) (11) (12) and is most likely responsible for expression of recessive alleles in coat color patches on heterozygous mice (10) . Analysis of heritable tumors in-humans has also provided evidence for mitotic recombination (13) (14) (15) .
Although the occurrence of mitotic recombination is no longer in doubt, its relative contribution to allele loss, compared with other mechanisms such as nondisjunction or deletion, has not been systematically evaluated. Selection for specific H-2 antigen-loss variants from heterozygous cells allowed us to examine the genetic events responsible for variant formation and to construct mitotic linkage maps for mouse chromosome 17. and MA87 were used in anti-H-2Db selections. These antibodies show no crossreactivity and were described previously (17, 18 Screening for H-2D Allele Loss. Antigen-loss variants were screened for allele loss by allele-specific oligonucleotide (ASO) hybridization to DNA amplified by the polymerase chain reaction (PCR) from cell lysates or from purified DNA. For crude lysates, cells were washed in phosphate-buffered saline and -6 x 105 cells were lysed by incubation at 550C in 100 pl of PCR buffer (50mM KCI/10mM Tris-HCI, pH 8.3/0.01% gelatin/2.5mM MgCl2) containing 0.45% Nonidet P-40, 0.45% Tween 20, and 0.06 mg of proteinase K per ml (19) . After lysis, the samples were incubated at 95°C for 10 min to inactivate proteases and were stored frozen. Two priming oligonucleotides (5'-GCTCTCACACACTCCAG-3' and 5'-TCCCGTTCTTCAGGTATCTG-3') that are completely homologous to sequences within the exon 3 of both H-2Db and H-2Dd were used to amplify a 254-base-pair (bp) segment of each allele in 10 ,l of the lysate in a 200-,l reaction mixture in PCR buffer containing 7.5 units of Taq polymerase and 0.05 ,mol of each primer. Thirty-seven cycles of95°C for 1 min, 53°C for 1 min, and72°C for 1 min were used, with increase of the 72°C incubation by 2 sec per cycle in a Perkin-Elmer/Cetus DNA thermal cycler. Amplified DNA was denatured and transferred to nylon with 0.4 M NaOH by using a dot blot vacuum manifold.32P-end-labeled ASOs homologous to b (AGCATTACAAGGCCTACC) or d (CT-GCAGAGAGAGACCGGG) allele sequences within this fragment were then used to discriminate between the two alleles (20) . The conditions for ASO hybridization have been described (21 (22) . The plasmids and loci they identify are as follows: pB1.4, Tcp-1 (t-complex protein 1) (23); TuOO, D17TuSO (24) ; Y44, Hba-ps4 (hemoglobin-a pseudogene 4) (25); Pim-lA, Pim-1 (proviral integration site, mink cell focus-forming virus) (26) ; pMaA, Crya-1 (a-crystallin 1) (27); 1-26, H-2K and other class I H-2 genes (28); and Tu49, D17Tu49 (24) .
MATERIALS AND METHODS
Southern Analysis. Aliquots (4 Ag) of DNA were digested with restriction enzyme according to the supplier's instructions and electrophoresed in 0.7-1% (wt/vol) agarose gels.
DNA samples from the F1 cell line and from each parental mouse strain were included as controls in every run. Alkaline transfer to nylon filters, hybridization, and washing were as described (21) .
RESULTS AND DISCUSSION
H-2b/H-2d heterozygous cell lines were established and were treated with either anti-H-2Dd or anti-H-2Db antibodies and complement to negatively select for specific antigen-loss variants. Note that selection was performed on individual cell cultures of -106 cells, that each culture was started from a small number of cells, and that only one variant clone was selected for analysis from each culture. According to principles established by Luria and Delbruck (29) , this greatly increases the probability that variants will arise during expansion of the culture and that each variant will represent an independent event. Cultures with outgrowth after selection were screened for cell surface expression of both the target and nontarget H-2D molecules by flow cytofluorimetry (Fig. lA). Cultures containing target antigen-negative cells were cloned for further analysis.
In addition to allele loss, two general categories of events can lead to specific antigen loss. The first includes mutations (Table  2) . With the exception of D17TuSO and Crya-J, unique restriction fragments distinguished the two chromosomes 17 in the cell lines used in these studies. For simplicity, alleles on the C57BL/6J mouse chromosome carrying the H-2b haplotype are designated B and those on the DBA/2J (H-2d) chromosome are designated D. The D allele of D17TuSO is distinguished by the presence of fragments not found in the B allele; hence, determination of loss ofthe B alleles for these loci would be equivocal and thus was not performed for variants arising from anti-H-2Db selections. In addition, the congenic strains C57BL/lOSn and B10.D2/oSn share the B allele at D17TuSO, so the F1 hybrid cell line from these two strains was noninformative for this locus. LTXB-O/Sv and LT/Sv mice share the B allele of Crya-l, so variants from this F1 cell line were noninformative for this marker. Based on Southern analysis, the allele-loss variants were scored as either heterozygous or homozygous for each marker (Fig. 2) .
The criteria for concluding that a variant arose through mitotic recombination are loss of the allele encoding the target antigen, homozygosity for the distal DJ7Tu49 marker, and heterozygosity for all genes centromeric to the putative recombination site. Fig. 2 shows that 50 of 136 allele-loss variants met these criteria. Eighty-two allele-loss variants appeared to be homozygous for all markers; the origin of these clones could be either chromosome loss or mitotic recombination between the centromere and the most proximal marker. Only 4 allele-loss variants could not be accounted for by either chromosome loss or a single mitotic crossover. Two of these 4 clones may represent multiple crossovers, while 1 appears to be a deletion encompassing the H-2D region. The fourth is extremely complex, with several novel fragments identified using a class I H-2 probe and alternating retention of either the B or D allele for proximal markers. In summary, identifiable single mitotic breakpoints can account for 37% of the allele-loss variants, with only 3% occurring because of more complex events. In the absence of a marker for the centromere, we cannot determine the relative contributions of chromosome loss and proximal recombination in the formation of the majority of the variants (60%).
Despite the lack of a marker for the centromere, a comparison of our results with the consensus meiotic map argues against the likelihood that all variant clones homozygous for every marker represent chromosome loss. Fig. 3 shows the locations of Tcp-1 on the meiotic maps and as deduced from these experiments. The estimated meiotic distance of Tcp-l from the centromere is -7.7 centimorgans, which is comparable to the interval of -5.7 centimorgans between Tcp-J and Hba-ps4 in which 22 mitotic crossovers were localized (Fig.  2) . Unless mitotic recombination in the Tcp-l-centromere interval is suppressed, it seems probable that some of the allele-loss variants homozygous for Tcp-J are due to mitotic recombination rather than chromosome loss. Although we currently are unable to quantify the proportion of variants due to chromosome loss, experiments that include a marker for the centromere should resolve this issue.
The mitotic and meiotic maps are colinear, with the gene order deduced from analysis of the allele-loss variants identical to that obtained by conventional transmission genetics (Fig. 3) . Map C is derived from the consensus meiotic map (30) with centimorgans converted to cumulative fractional distance in the unit interval between Tcp-l and the target locus, H-2D. Map D was derived from the data in Table 2 and was constructed in the same unit interval to allow convenient comparison with the meiotic map. All 50 variants resulting from single mitotic crossovers in the Tcp-J-H-2D interval were informative for Hba4ps, Pim-J, and H-2K (Fig. 3, map  D) . Although the expansion of the Hba-ps4-Pim-J interval and contraction of the Pim-1-H-2K interval in the mitotic map are statistically significant (P 0.02, x2 analyses), it would be imprudent to attribute these small quantitative differences to varying recombinatorial mechanisms in meio- 
No. (32) (33) (34) (35) . One example is the large intron of the H-2Eb gene which has been identified as a preferred site for intra-H-2 meiotic recombination in several independent recombinant mice. Recently, hypervariable minisatellite DNA sequences, such as those associated with this intra-H-2 recombinational hotspot, have been shown to enhance homologous recombination between plasmids in mitotically active cells (36) . The (30) . For coalparison of mitotic and meiotic maps, the distance to H-2D was assigned a value of 1 and distance was indicated by the fraction of recombinants (mitotic) or centimorgans (meiotic) occurring in each interval. Note that in meiotic map A the unit distance starts at a small, but undetermined, distance from the centromere, while mitotic map B starts beyond the centromere, indicating that this interval may include chromosome-loss variants as well as mitotic recombinants. In maps C (meiotic) and D (mitotic), the Tcp-I-H-2D interval is portrayed as a unit interval, with distances again represented fractionally. All 50 mitotic recombinants were informative for the markers shown on the left in map D, whereas fewer variants were informative in positioning D17Tu5O (n = 11) and Crya-J (n = 6) as shown on the right side of map D. Allele-loss variants that could not be attributed to a single mitotic crossover (illustrated in the bottom four rows of Fig. 2) were not included in the construction of the mitotic maps. Note the colinearity and similarity of the mitotic and meiotic maps. breakpoint in the single mitotic recombinant between H-2K and H-2D occurred in the physically large interval between H-2Ea and H-2D (data not shown), the same region in which the majority of intra-H-2 meiotic crossovers occur (37) . Whether meiotic recombinational hotspots are also preferred in interchromosomal mitotic recombination is unknown.
It seems likely that the use of some recombinational hotspots will be restricted to meiosis, where specific mechanisms to enhance homologous interchromosomal exchange may have evolved. For example, in vitro recombination between two long terminal repeats of a retrotransposon was greatly enhanced in extracts from mouse testes, but not in extracts from mitotically active somatic cells (38) ; given the differences in hotspot activity between mitotic and meiotic cells in lower eukaryotes (39) (40) (41) , it is possible that this reflects differences in meiotic and mitotic recombination. Other events, such as the double-strand breaks resulting from irradiation, enhance the frequency of both mitotic and meiotic recombination (10) . Refining our mitotic maps may reveal mitosis-specific hotspots.
Selection for antigen-loss variants also provides a defined system to study the effects of mutations affecting recombination and DNA repair as an approach to defining mitotic recombinatorial mechanisms. For example, our preliminary results suggest a higher incidence of allele loss and mitotic recombination in a cell line from an F1 mouse homozygous for the severe combined immunodeficiency (scid) mutation. Such scid/scid mice are deficient in their ability to effect productive rearrangement of immunoglobulin and T-cell receptor genes and have recently been shown to have a more generalized defect in DNA repair (42, 43) ; no influence of the scid mutation on meiotic recombination has been described.
The importance of mitotic recombination to oncogenesis and tumor progression has become increasingly apparent in recent years, but analysis of this phenomenon at the level of whole chromosomes is experimentally accessible in only a small number of systems. Our experiments demonstrate that mitotic recombination is a common event leading to allele loss, in spite of the lack of evidence for frequent somatic pairing of homologous chromosomes. Further exploitation of this system, in addition to defining the chromosomal patterns and mechanisms of mitotic recombination, may lead to practical advances for elucidating somatic mechanisms of oncogenesis, for genome mapping through somatic cell approaches, and for gene therapy in targeting genes to specific sites through homologous recombination.
